Levi & Korsinsky Reminds Shareholders of an Investigation into Pliant Therapeutics, Inc. (PLRX) Regarding Potential Securities Fraud Allegations
NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ...
Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight
DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...
Too Old to Operate14h
Easy-to-Apply Tool Streamlines Dyspnea Evaluation in Urgent Care
Effective dyspnea evaluation in urgent care requires the usage of a systems-based framework for categorizing the differential ...
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...
Doctor Advises One Delicious Snack ‘Can Decrease’ Risk of Hangover
A pulmonary doctor and TikTok influencer shared advice on one snack that “can decrease” risk of a hangover following a night ...
Managed Healthcare Executive3d
More Results for Nerandomilast Reported by BI, This Time for Progressive Pulmonary Fibrosis
Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...
TMCnet5d
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
In connection with the offering, David Liu, a Senior Analyst at Velan Capital, was appointed to Edesa’s Board of Directors, effective immediately upon closing, pursuant to an Investor Rights Agreement ...